Tec de Monterrey has officially announced a cannabis diploma program that will open the door to a stronger conversation about cannabis. The main objective of this diploma is to provide tools to the health sector for the responsible use of cannabis (in medical terms). Countries like Canada have demonstrated that the advantages outweigh the disadvantages when using cannabis in medical treatments.
The International Diploma of Medicinal Cannabis in Latin America has been announced by the Tec de Monterrey and is aimed at the medical sector that wishes to learn and professionalize the practices of the use of the plant that has proven worldwide to be much more positive than anyone could imagine. Through the School of Medicine and Health Sciences (EMCS) TecSalud of the institution and one of the leading pioneers in the industry, Khiron Life Sciences Corp. comes this diploma course that will begin on February 20, 2021.
The main objective of this diploma is to provide tools to the health sector to help the responsible use of the benefits of cannabis (in medical terms) and the reason for its medical prescription for those countries that are advancing in this sector by opening the doors to cannabis.
“The use of cannabis is a priority health issue that we have been analyzing previously. Since 2014, we participated in the health section of the book ‘The Lesser Evil in Drug Management: from Management to Regulation’ providing information on medical cannabis from the academic perspective due to the multiple implications it has,” says Dr. Jorge E. Valdez, dean of the EMCS. “The course will address the potential of the medicinal use of CBD, with seriousness and academic support for the benefit of the community,” added the doctor.
Countries such as Canada have recently demonstrated that the advantages outweigh the disadvantages when applying or using elements of cannabis in medical treatments. The first step was taken by using it on terminal cancer patients who, according to their own testimonies, the plant helps them to lead a much more humane life in the most difficult moments. “The development of this diploma represents a significant advance in the medical cannabis industry in Latin America, and reinforces medical education about the usefulness of cannabis derivatives in the symptomatic treatment of chronic pain and other neurological and psychiatric disorders that can benefit millions of patients,” said Guillermo Moreno Sanz, Scientific and Medical Director of Khiron Europe when exploring the benefits of the International Diploma of Medical Cannabis in Latin America.
Doctors Ethan Russo, Michael Boivin, and Mexico’s Alfredo Covarrubias are just some of the experts who will participate in the 120-hour program, which will be conducted virtually. “Doctors will understand the use of medical cannabis, whether oral, inhaled, or topical; they will also be able to analyze in which patients their CBD derivatives, THC or both (as long as the latter is authorized), since the use in each person is very important,” says Dr. Fernando Cantú, Academic Director of the Medical Specialty of Anesthesiology and Clinical Director of the Pain and Palliative Care Clinic of Tec Salud regarding his program.
In countries around the world, mainly in the United States, it has become a trend to specialize in careers, diplomas, or master’s degrees in cannabis. Here are some examples of how to professionalize this subject.
Thanks to the Regulations for the Production, Research and Medicinal Use of Cannabis and its Derivatives that came into force in Mexico, these types of practices related to the plant are beginning to be not only legal, but also the central axis of an advanced conversation that promises to explore the most positive aspects of a natural element that demonstrates its properties and benefits worldwide.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in GQ, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.